Table 2 Base results of pembrolizumab versus chemotherapy
Strategy | Chemotherapy | Pembrolizumab |
|---|---|---|
Cost | $2734.55 | $39710.96 |
Overall LYs | 3.93 | 3.96 |
QALYs | 2.73 | 2.82 |
Incr Cost | Â | $36976.41 |
Incr Eff (LYs) | Â | 0.03 |
Incr Eff (QALYs) | 0.09 | |
ICER(USD per additional LY gained) | $1232547.00 | |
ICER(USD per additional QALY gained) | $422535.53 | |